Rac-Sitagliptin D4 | CAS 1620233-72-8 - Request Quote
Rac-Sitagliptin D4
| SZ CAT No: | SZ-S009D02 |
| CAS No | 1620233-72-8 |
| Mol.F. | C16H11D4F6N5O |
| Mol.Wt. | 411.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rac-Sitagliptin D4 is chemically 3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-5,5,6,6-d4)-4-(2,4,5-trifluorophenyl)butan-1-one. Rac-Sitagliptin D4 is supplied with detailed characterization data compliant with regulatory guideline. Rac-Sitagliptin D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sitagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1620233-72-8
Purchase 1620233-72-8
Order 1620233-72-8
Enquire 1620233-72-8
price of 1620233-72-8
1620233-72-8 Supplier
1620233-72-8 Manufacturer
1620233-72-8 Exporter
buy high quality Rac-Sitagliptin D4
Purchase Rac-Sitagliptin D4
Rac-Sitagliptin D4 suppliers
Rac-Sitagliptin D4 manufacturers
Rac-Sitagliptin D4 price
Order Rac-Sitagliptin D4
Enquire Rac-Sitagliptin D4
Rac-Sitagliptin D4 cost
Rac-Sitagliptin D4 Supplier
Rac-Sitagliptin D4 Distributor
Rac-Sitagliptin D4 for Method Validation
Sitagliptin Reference Standard
Rac-Sitagliptin D4 for ANDA Filing
Rac-Sitagliptin D4 for Forced Degradation Studies
Rac-Sitagliptin D4 Identification Standards
Rac-Sitagliptin D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


